Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report released on Friday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.80 on Friday. The firm has a fifty day simple moving average of $0.46 and a 200-day simple moving average of $0.43. The company has a market capitalization of $11.17 million, a PE ratio of -0.28 and a beta of 1.61. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.23.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.